Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation
Authors
Keywords
-
Journal
JOURNAL OF PINEAL RESEARCH
Volume 60, Issue 1, Pages 27-38
Publisher
Wiley
Online
2015-10-07
DOI
10.1111/jpi.12285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal
- (2015) Shulin Xiang et al. JOURNAL OF PINEAL RESEARCH
- Melatonin: Physiological effects in humans
- (2015) B. Claustrat et al. NEUROCHIRURGIE
- Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base
- (2014) Lauren E. Colbert et al. CANCER
- Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
- (2014) Laura Tornatore et al. CANCER CELL
- Melatonin: functions and ligands
- (2014) Mahaveer Singh et al. DRUG DISCOVERY TODAY
- Transport properties of pancreatic cancer describe gemcitabine delivery and response
- (2014) Eugene J. Koay et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation
- (2014) H.-Q. Ju et al. MOLECULAR CANCER THERAPEUTICS
- Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis
- (2014) Zhe Chang et al. PLoS One
- Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer
- (2013) Takeshi Gocho et al. CANCER LETTERS
- Deciphering the Mechanisms of Tumorigenesis in Human Pancreatic Ductal Epithelial Cells
- (2013) Z. Chang et al. CLINICAL CANCER RESEARCH
- Roles for KRAS in Pancreatic Tumor Development and Progression
- (2013) Marina Pasca di Magliano et al. GASTROENTEROLOGY
- An Undesired Effect of Chemotherapy
- (2013) Sumit Arora et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells
- (2013) Raquel Ordoñez et al. JOURNAL OF PINEAL RESEARCH
- The role of melatonin in the cells of the innate immunity: a review
- (2013) Juan R. Calvo et al. JOURNAL OF PINEAL RESEARCH
- NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies
- (2013) Carmela R Balistreri et al. Immunity & Ageing
- Melatonin is involved in the apoptosis and necrosis of pancreatic cancer cell line SW-1990 via modulating of Bcl-2/Bax balance
- (2012) Chunfang Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma
- (2012) Jianhua Ling et al. CANCER CELL
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
- (2012) Meredith A. Collins et al. JOURNAL OF CLINICAL INVESTIGATION
- Dimethylamino Parthenolide Enhances the Inhibitory Effects of Gemcitabine in Human Pancreatic Cancer Cells
- (2012) Bryan K. Holcomb et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling
- (2012) Dingbo Shi et al. JOURNAL OF PINEAL RESEARCH
- Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways
- (2012) Jingshu Wang et al. JOURNAL OF PINEAL RESEARCH
- ABO blood group, hepatitis B viral infection and risk of pancreatic cancer
- (2011) De-Shen Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
- (2011) Davide Melisi et al. JNCI-Journal of the National Cancer Institute
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
- (2011) Bin Bao et al. PLoS One
- Conditional ablation of Ikkb inhibits melanoma tumor development in mice
- (2010) Jinming Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Pancreatic cancer: understanding and overcoming chemoresistance
- (2010) Zhiwei Wang et al. Nature Reviews Gastroenterology & Hepatology
- Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation
- (2009) Zhanqing Li et al. JOURNAL OF PINEAL RESEARCH
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- NF-κB in carcinoma therapy and prevention
- (2008) Matthew Brown et al. EXPERT OPINION ON THERAPEUTIC TARGETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More